Proposal to make opioid makers pay for treatment becomes law
A new Maine law sets a licensing fee for manufacturers of opioids doing business in the state as part of an effort to hold the companies accountable for opioid use disorder. Senate President Troy Jackson, a Democrat, proposed the law change, and it became law without the signature of Democratic Gov. Janet Mills over the weekend. The law change allows Maine to collect information from the opioid manufacturers, and the state will use funds from the fees collected to help pay for treatment and recovery programs. The licensing fee is $55,000.